Diego A. Díaz García, Medical Oncologist / CEO / Founder at CánCare – Advanced Specialty in Oncology, shared a post on X
“Survival of pts with Lung Adenocarcinoma diagnosed in 2000, 2010, and 2020. Median OS in lung adenocarcinoma more than doubled in 20 years (8.5 → 20.7 months) in non-academic public hospitals in France.
Targeted therapy and immunotherapy significantly improved outcomes, even outside academic centers. “
You can read the article here
You can also read about Immunotherapy for Lung Cancer
